Literature DB >> 28546244

Is Hippocampal Volumetry Really All That Matters?

S Haller1,2,3,4.   

Abstract

Mesh:

Year:  2017        PMID: 28546244      PMCID: PMC7963696          DOI: 10.3174/ajnr.A5250

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  15 in total

1.  Susceptibility weighted imaging in dementia with Lewy bodies: will it resolve the blind spot of MRI?

Authors:  Sven Haller; David Fällmar; Elna-Marie Larsson
Journal:  Neuroradiology       Date:  2015-10-12       Impact factor: 2.804

2.  Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Authors:  B C Dickerson; T R Stoub; R C Shah; R A Sperling; R J Killiany; M S Albert; B T Hyman; D Blacker; L Detoledo-Morrell
Journal:  Neurology       Date:  2011-04-13       Impact factor: 9.910

3.  Interaction of Vascular Damage and Alzheimer Dementia: Focal Damage and Disconnection.

Authors:  Sven Haller; Frederik Barkhof
Journal:  Radiology       Date:  2017-02       Impact factor: 11.105

4.  Basic MR sequence parameters systematically bias automated brain volume estimation.

Authors:  Sven Haller; Pavel Falkovskiy; Reto Meuli; Jean-Philippe Thiran; Gunnar Krueger; Karl-Olof Lovblad; Tobias Kober; Alexis Roche; Bénédicte Marechal
Journal:  Neuroradiology       Date:  2016-09-13       Impact factor: 2.804

5.  Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study.

Authors:  Koji Kamagata; Tomoya Nakatsuka; Ryuji Sakakibara; Yohei Tsuyusaki; Tomohiro Takamura; Kanako Sato; Michimasa Suzuki; Masaaki Hori; Kanako K Kumamaru; Tsutomu Inaoka; Shigeki Aoki; Hitoshi Terada
Journal:  Neuroradiology       Date:  2016-12-29       Impact factor: 2.804

6.  Predictive Utility of Marketed Volumetric Software Tools in Subjects at Risk for Alzheimer Disease: Do Regions Outside the Hippocampus Matter?

Authors:  T P Tanpitukpongse; M A Mazurowski; J Ikhena; J R Petrella
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-05       Impact factor: 3.825

7.  Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease.

Authors:  Lyduine E Collij; Fiona Heeman; Joost P A Kuijer; Rik Ossenkoppele; Marije R Benedictus; Christiane Möller; Sander C J Verfaillie; Ernesto J Sanz-Arigita; Bart N M van Berckel; Wiesje M van der Flier; Philip Scheltens; Frederik Barkhof; Alle Meije Wink
Journal:  Radiology       Date:  2016-07-06       Impact factor: 11.105

8.  Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment.

Authors:  Laurence O'Dwyer; Franck Lamberton; Arun L W Bokde; Michael Ewers; Yetunde O Faluyi; Colby Tanner; Bernard Mazoyer; Desmond O'Neill; Máiréad Bartley; D Rónán Collins; Tara Coughlan; David Prvulovic; Harald Hampel
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

9.  Evaluating Alzheimer's disease progression using rate of regional hippocampal atrophy.

Authors:  Edit Frankó; Olivier Joly
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

10.  The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals.

Authors:  Bradford C Dickerson; Akram Bakkour; David H Salat; Eric Feczko; Jenni Pacheco; Douglas N Greve; Fran Grodstein; Christopher I Wright; Deborah Blacker; H Diana Rosas; Reisa A Sperling; Alireza Atri; John H Growdon; Bradley T Hyman; John C Morris; Bruce Fischl; Randy L Buckner
Journal:  Cereb Cortex       Date:  2008-07-16       Impact factor: 5.357

View more
  1 in total

1.  Dementia imaging in clinical practice: a European-wide survey of 193 centres and conclusions by the ESNR working group.

Authors:  M W Vernooij; F B Pizzini; R Schmidt; M Smits; T A Yousry; N Bargallo; G B Frisoni; S Haller; F Barkhof
Journal:  Neuroradiology       Date:  2019-03-09       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.